Oswald Clark, U.S. Correspondent: On May 14, the Supreme Court of the United States permitted the on-going mail distribution of the abortion pill when it stayed a lower court decision that sided with the state of Louisiana in its challenge against the Food and Drug Administration’s 2023 rule that allowed mifepristone to be prescribed and dispensed without an in-person appointment. Danco Laboratories [...]
You are unauthorized to view this entire article. Please log in to your account to receive full access to The Interim.
